ScoreWhy is SkinBioTherapeutics Plc ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate -15.69% of over the last 5 years
3
Positive results in Dec 24
- NET SALES(HY) Higher at GBP 1.58 MM
- ROCE(HY) Highest at -63.28%
- INVENTORY TURNOVER RATIO(HY) Highest at 2.8%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -11.78%, its profits have risen by 10.4%
5
Underperformed the market in the last 1 year
- Even though the market (FTSE 100) has generated returns of 15.94% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -11.78% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to SkinBioTherapeutics Plc should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is SkinBioTherapeutics Plc for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
SkinBioTherapeutics Plc
-14.76%
1.37
51.47%
FTSE 100
16.5%
1.23
12.99%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.77%
EBIT Growth (5y)
-15.69%
EBIT to Interest (avg)
-2.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.15
Tax Ratio
0.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.62
EV to EBIT
-13.29
EV to EBITDA
-14.91
EV to Capital Employed
7.97
EV to Sales
12.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-60.00%
ROE (Latest)
-57.38%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for SkinBioTherapeutics Plc
Net Sales
Higher at GBP 1.58 MM
than preceding 12 month period ended Dec 2024MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (GBP MM)
Inventory Turnover Ratio
Highest at 2.8% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 5.93% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Profit
Highest at GBP -0.88 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (GBP MM)
Pre-Tax Profit
Highest at GBP -1.04 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (GBP MM)
Net Profit
Highest at GBP -1.03 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
EPS
Highest at GBP -0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (GBP)
Raw Material Cost
Fallen by -21.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for SkinBioTherapeutics Plc
Operating Cash Flow
Lowest at GBP -5.22 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (GBP MM)
Interest
At GBP 0.01 MM has Grown at 49.95%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (GBP MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
